Associated Banc Corp cut its holdings in shares of Roche Holding Ltd. (OTCMKTS:RHHBY) by 2.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 78,050 shares of the company’s stock after selling 2,285 shares during the period. Associated Banc Corp’s holdings in Roche were worth $2,467,000 as of its most recent SEC filing.
Other hedge funds have also recently modified their holdings of the company. NorthCoast Asset Management LLC lifted its holdings in shares of Roche by 1.1% during the fourth quarter. NorthCoast Asset Management LLC now owns 185,347 shares of the company’s stock valued at $5,860,000 after purchasing an additional 1,978 shares in the last quarter. Delaney Dennis R lifted its holdings in shares of Roche by 160.8% during the fourth quarter. Delaney Dennis R now owns 26,900 shares of the company’s stock valued at $850,000 after purchasing an additional 16,585 shares in the last quarter. Puzo Michael J lifted its holdings in shares of Roche by 43.0% during the fourth quarter. Puzo Michael J now owns 121,723 shares of the company’s stock valued at $3,843,000 after purchasing an additional 36,610 shares in the last quarter. Kidder Stephen W increased its position in Roche by 1.7% during the fourth quarter. Kidder Stephen W now owns 119,660 shares of the company’s stock valued at $3,779,000 after acquiring an additional 1,989 shares during the last quarter. Finally, Hemenway Trust Co LLC increased its position in Roche by 1.3% during the fourth quarter. Hemenway Trust Co LLC now owns 241,444 shares of the company’s stock valued at $7,625,000 after acquiring an additional 3,161 shares during the last quarter. 0.58% of the stock is currently owned by institutional investors.
A number of analysts have commented on RHHBY shares. ValuEngine upgraded Roche from a “hold” rating to a “buy” rating in a research report on Tuesday, January 16th. Zacks Investment Research upgraded Roche from a “hold” rating to a “buy” rating and set a $35.00 target price for the company in a research report on Tuesday, January 2nd. Berenberg Bank lowered Roche from a “buy” rating to a “hold” rating in a research note on Tuesday, October 24th. JPMorgan Chase & Co. reissued an “overweight” rating on shares of Roche in a research note on Friday, December 29th. Finally, Piper Jaffray Companies reissued a “buy” rating on shares of Roche in a research note on Thursday, December 7th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $36.50.
Roche Holding Ltd. (RHHBY) opened at $30.30 on Tuesday. Roche Holding Ltd. has a fifty-two week low of $28.48 and a fifty-two week high of $36.82. The company has a quick ratio of 0.92, a current ratio of 1.29 and a debt-to-equity ratio of 0.66.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/20/associated-banc-corp-trims-position-in-roche-holding-ltd-rhhby.html.
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.